Navigation Links
US Pharmacopeia announces revised heparin monographs and reference standards
Date:6/23/2008

Rockville, Md., June 23, 2008 The U.S. Pharmacopeial (USP) Convention announces that revised monographs for heparin sodium and heparin calcium in the United States Pharmacopeia (USP) are now available and official on the USP Web site. The revised monographs are accompanied by two new and two updated official USP Reference Standards. These public standards allow any partyand particularly the Food and Drug Administration (FDA) and manufacturersto test heparin sodium and calcium drug substances to assure their quality. All drug manufacturers who market heparin in the United States are required to meet these newly revised standards. The heparin monographs were updated in the interest of public health following the deaths of more than 200 people earlier this year. These deaths are suspected to have resulted from the adulteration of the blood thinner with over-sulfated chondroitin, which is derived from the chemical chondroitin and used in dietary supplements.

The two heparin monographs are posted on the USP Web site at http://www.usp.org/hottopics/heparin.html?hlc. These revisions mark the end of the first stage (Stage 1) of a multi-stage process to revise the monographs. The Stage 1 revision was intended to rapidly address the immediate public health crisis associated with the drug and help ensure an unadulterated supply of heparin by taking proposed methods from the FDA and improving their robustness. The second stage of revision (Stage 2) will seek out additional methods to test for over-sulfated chondroitin and other potential contaminants in heparin. USP co-sponsored a meeting June 19-20, 2008, in Strasbourg, France, with the European Directorate for the Quality of Medicines (the organization that elaborates the European Pharmacopoeia) and the United Kingdom's National Institute for Biological Standards and Control as part of a coordinated, worldwide effort to assure the quality and purity of heparin.

"The expedited revision of USP's heparin standards gives manufacturers, health care practitioners and patients increased confidence that this widely used drug is free of this adulterant," said Roger L. Williams, M.D., USP executive vice president and CEO. "The monograph revisions were completed quickly to alleviate a major public health concern; they were accomplished through USP's established, transparent, and scientific process. In updating the standards, USP received guidance not only from the FDA but also from the volunteer experts on USP's Heparin Advisory Panel and USP's Blood and Blood Products Expert Committee, which concluded the monograph standards, and USP's Reference Standards Committee, which endorsed the physical standards. USP thanks these colleagues and the many other national and international experts who assisted the USP Council of Experts' Expert Committees and Advisory Panel and worked with us to meet this extremely important challenge."

USP publishes official quality standards for medicines in the United States PharmacopeiaNational Formulary (USPNF) and has worked with FDA for more than 100 years in a unique public-private partnership that helps to assure the quality of medicines in the United States. The availability of a good public monograph in the USPNF along with allied reference materials is one of a series of safety nets that help assure that U.S. patients and practitioners have access to good quality medicines.

"While USP monographs are generally designed to test for known impurities that may result from the manufacturing process or degradation, and not for unknown contaminants that may be added either accidentally or deliberately, we were pleased to modify our standards to help alleviate patient danger associated with the heparin product and will continue to explore methods for detecting potential contaminants," Dr. Williams noted.


'/>"/>

Contact: Laura Provan
lnp@usp.org
301-816-8268
US Pharmacopeia
Source:Eurekalert

Related medicine news :

1. U.S. Pharmacopeia Aiding FDA in Improved Tests for Heparin Contamination
2. U.S. Pharmacopeia Releases New Edition of the Food Chemicals Codex
3. US Pharmacopeia releases new edition of the Food Chemicals Codex
4. Pharmacopeia to Present at The Roth 20th Annual OC Growth Stock Conference
5. USP publishes Spanish edition of United States Pharmacopeia and National Formulary
6. USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary
7. U.S. Pharmacopeia 8th Annual MEDMARX(R) Report Indicates Look-Alike/Sound-Alike Drugs Lead to Thousands of Medication Errors Nationwide
8. US Pharmacopeia partners with Quantros to enhance the MEDMARX patient safety reporting program
9. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
10. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
11. Pharmacopeia Announces Senior Additions to Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , ... May 25, 2016 , ... America Walks ... Carol Reichbaum, M.S.L., M.S.P.A., of the University of Pittsburgh Graduate School of Public ... will enable Ms. Reichbaum and 24 other advocates from around the country to participate ...
(Date:5/25/2016)... , ... May 25, 2016 , ... Researchers from SUNY ... COVD Meeting for their work on visual evoked potential and human attention. The article, ... that used the Diopsys® NOVA™ ERG and VEP Vision Testing System (Diopsys, ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... demand for minimally invasive, endoscopic spine surgeries in the Montgomery County, Howard County ... patients in the Germantown office of American Spine every Monday. He will also ...
(Date:5/24/2016)... , ... May 24, 2016 , ... To better understand ... new research award to examine gender differences in lung cancer. Today, the Lung Association ... Project: Lung Cancer in Women Award, funded by the American Lung Association’s LUNG FORCE ...
(Date:5/24/2016)... ... May 24, 2016 , ... United Benefit Advisors (UBA), the ... Firm Austin & Co., Inc. Headquartered in Albany, New York, Austin & ... benefits technology, and beyond. As an employee-owned company celebrating over 160 years ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... 2016  Granger Diagnostics today announced immediate availability of ... infections. This test ensures discovery of ALL bacteria, ... test requires only a simple swab of the wound ... G. Bostwick , MD, Chief Medical Officer, described ... "We are excited to make available, for the ...
(Date:5/25/2016)... May 25, 2016 MedDay, a biotechnology ... that an oral presentation entitled "High doses of biotin in ... will be given by Professor Ayman Tourbah , Principal ... of the European Academy of Neurology (EAN) in ... disorders 3" will take place on Sunday, 29 May 2016 ...
(Date:5/25/2016)... May 25, 2016 ReportsnReports.com ... research report that provides an overview on therapeutic ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ... key players involved in the therapeutic development for ...
Breaking Medicine Technology: